蓝帆医疗股份有限公司第六届董事会第三十九次会议决议公告

Group 1 - The company held its 39th meeting of the sixth board of directors on February 24, 2026, via electronic communication, with all 8 directors participating [2][3] - The board proposed to lower the conversion price of the "Blue Sail Convertible Bond" due to the stock price being below 85% of the conversion price for at least 15 out of the last 30 trading days, which triggers the adjustment condition [3][30] - The proposed adjustment will be submitted to the shareholders' meeting for approval, and the new conversion price must not be lower than the higher of the average stock price over the 20 trading days prior to the shareholders' meeting and the last trading day's price, nor lower than the latest audited net asset value per share and the par value [3][30] Group 2 - The company plans to hold the second extraordinary shareholders' meeting of 2026 on March 16, 2026, to discuss the proposed adjustment of the conversion price [7][8] - The meeting will be conducted both in-person and via online voting, with specific time slots for voting provided [36][46] - Shareholders holding the convertible bonds must abstain from voting on the proposal to adjust the conversion price [43]